Evidence map›Paper›PMID 26292319›Full record

ArticleJournal of virology2015

Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1.

Hongjie Wang, Corinne Ducournau, Kamola Saydaminova, Maximilian Richter, Roma Yumul, Martin Ho, Darrick Carter, Chloé Zubieta, Pascal Fender, André Lieber

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cardiomyocyte cohesion is increased after ADAM17 inhibition.Frontiers in cell and developmental biology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Immune Responses to Viral Gene Therapy Vectors.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Hongjie WangDivision of Medical Genetics, University of Washington, Seattle, Washington, USA.
Corinne DucournauUnit of Virus Host Cell Interactions, UMI3265, CNRS/EMBL/UJF, Grenoble, France.
Kamola SaydaminovaDivision of Medical Genetics, University of Washington, Seattle, Washington, USA.
Maximilian RichterDivision of Medical Genetics, University of Washington, Seattle, Washington, USA.
Roma YumulDivision of Medical Genetics, University of Washington, Seattle, Washington, USA.
Martin HoDivision of Medical Genetics, University of Washington, Seattle, Washington, USA.
Darrick CarterCompliment Corporation, Seattle, Washington, USA.
Chloé ZubietaEuropean Synchrotron Radiation Facility, Grenoble, France.
Pascal FenderUnit of Virus Host Cell Interactions, UMI3265, CNRS/EMBL/UJF, Grenoble, France lieber00@u.washington.edu pfender@embl.fr.
André LieberDivision of Medical Genetics, University of Washington, Seattle, Washington, USA Department of Pathology, University of Washington, Seattle, Washington, USA Compliment Corporation, Seattle, Washington, USA lieber00@u.washington.edu pfender@embl.fr.
University of Washington Medical Center · USUnit of Virus Host Cell Interactions · FRCompliment Corporation (United States) · USEuropean Synchrotron Radiation Facility · FR

Funding

Vaccinating against IGFBP-2 to prevent ovarian cancer relapseP50CA083636 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DRESCHER, CHARLES, URBAN, NICOLE DENISE · 1999 to 2015
$35.1M
ONCOLYTIC ADENOVIRUSES FOR CERVICAL CANCER GENE THERAPYR01CA080192 · NCI · UNIVERSITY OF WASHINGTON · PI LIEBER, ANDRE MICHAEL · 1999 to 2009
$2.0M
NCI NIH HHS P50 CA083636NCI NIH HHS P50 CA83636NCI NIH HHS R01 CA080192PHS HHS R01 HLA078836
6 · The paper itself

Abstract

unlabelledWe recently discovered that desmoglein 2 (DSG2) is a receptor for human adenovirus species B serotypes Ad3, Ad7, Ad11, and Ad14. Ad3 is considered to be a widely distributed human pathogen. Ad3 binding to DSG2 triggers the transient opening of epithelial junctions. Here, we further delineate the mechanism that leads to DSG2-mediated epithelial junction opening in cells exposed to Ad3 and recombinant Ad3 fiber proteins. We identified an Ad3 fiber knob-dependent pathway that involves the phosphorylation of mitogen-activated protein (MAP) kinases triggering the activation of the matrix-metalloproteinase ADAM17. ADAM17, in turn, cleaves the extracellular domain of DSG2 that links epithelial cells together. The shed DSG2 domain can be detected in cell culture supernatant and also in serum of mice with established human xenograft tumors. We then extended our studies to Ad14 and Ad14P1. Ad14 is an important research and clinical object because of the recent appearance of a new, more pathogenic strain (Ad14P1). In a human epithelial cancer xenograft model, Ad14P1 showed more efficient viral spread and oncolysis than Ad14. Here, we tested the hypothesis that a mutation in the Ad14P1 fiber knob could account for the differences between the two strains. While our X-ray crystallography studies suggested an altered three-dimensional (3D) structure of the Ad14P1 fiber knob in the F-G loop region, this did not significantly change the fiber knob affinity to DSG2 or the intracellular signaling and DSG2 shedding in epithelial cancer cells. IMPORTANCE: A number of widely distributed adenoviruses use the epithelial junction protein DSG2 as a receptor for infection and lateral spread. Interaction with DSG2 allows the virus not only to enter cells but also to open epithelial junctions which form a physical barrier to virus spread. Our study elucidates the mechanism beyond virus-triggered junction opening with a focus on adenovirus serotype 3. Ad3 binds to DSG2 with its fiber knob domain and triggers intracellular signaling that culminates in the cleavage of the extracellular domain of DSG2, thereby disrupting DSG2 homodimers between epithelial cells. We confirmed this pathway with a second DSG2-interacting serotype, Ad14, and its recently emerged strain Ad14P1. These new insights in basic adenovirus biology can be employed to develop novel drugs to treat adenovirus infection as well as be used as tools for gene delivery into epithelial tissues or epithelial tumors.

Indexed as

Models, MolecularADAM17 ProteinADAM ProteinsAdenoviruses, HumanAnalysis of VarianceAnimalsBlotting, WesternCrystallography, X-RayDesmoglein 2Extracellular Signal-Regulated MAP KinasesHEK293 CellsHeLa CellsHumansMicePhosphorylationSerogroupADAM17 ProteinADAM17 protein, humanAdam17 protein, mouseADAM ProteinsDesmoglein 2Extracellular Signal-Regulated MAP Kinases

Identifiers

PMID26292319
PMCPMC4621136
OpenAlexW1819766659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.